{"id":568,"date":"2026-03-02T16:19:02","date_gmt":"2026-03-02T14:19:02","guid":{"rendered":"http:\/\/example.test\/?page_id=568"},"modified":"2026-03-25T10:58:50","modified_gmt":"2026-03-25T08:58:50","slug":"dpp-4-degradation-peptide-engineering","status":"publish","type":"page","link":"https:\/\/life-peptide.com\/cs\/dpp-4-degradation-peptide-engineering\/","title":{"rendered":"Degradace DPP-4 a strukturn\u00ed in\u017een\u00fdrstv\u00ed inkretinov\u00fdch analog\u016f"},"content":{"rendered":"<h1 class=\"wp-block-heading has-text-align-center\"><strong>Degradace DPP-4 a strukturn\u00ed in\u017een\u00fdrstv\u00ed inkretinov\u00fdch analog\u016f<\/strong><\/h1>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><strong>Enzymatick\u00e1 nestabilita a strategie prodlou\u017een\u00ed polo\u010dasu v oblasti v\u00fdzkumu GLP-1<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nativn\u00ed incretinov\u00e9 hormony, jako jsou GLP-1 a GIP, jsou v krevn\u00edm ob\u011bhu rychle degradov\u00e1ny enzymem dipeptidyl peptid\u00e1zou-4 (DPP-4), co\u017e vede k extr\u00e9mn\u011b kr\u00e1tk\u00fdm biologick\u00fdm polo\u010das\u016fm. V metabolick\u00e9m v\u00fdzkumu se struktur\u00e1ln\u00ed in\u017een\u00fdrstv\u00ed peptid\u016f vyu\u017e\u00edv\u00e1 k p\u0159ekon\u00e1n\u00ed t\u00e9to rychl\u00e9 enzymatick\u00e9 degradace a prodlou\u017een\u00ed farmakokinetick\u00e9 stability.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pochopen\u00ed \u0161t\u011bpen\u00ed DPP-4 a strategi\u00ed prodlou\u017een\u00ed polo\u010dasu je kl\u00ed\u010dov\u00e9 p\u0159i porovn\u00e1v\u00e1n\u00ed:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nativn\u00ed GLP-1<\/li>\n\n\n\n<li>Dlouhodob\u011b p\u016fsob\u00edc\u00ed agonisty GLP-1 receptor\u016f (nap\u0159. semaglutid)<\/li>\n\n\n\n<li>Du\u00e1ln\u00ed a trikretinov\u00e9 analogy<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Pro \u0161ir\u0161\u00ed srovn\u00e1n\u00ed na \u00farovni receptor\u016f viz na\u0161e <strong><a href=\"\/cs\/glp-1-metabolic-research-guide\/\" data-type=\"page\" data-id=\"529\">Pr\u016fvodce metabolick\u00fdm v\u00fdzkumem GLP-1.<\/a><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>1. P\u0159irozen\u00fd GLP-1 a rychl\u00e9 \u0161t\u011bpen\u00ed DPP-4<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Endogenn\u00ed GLP-1 (7\u201336 amid) je rychle inaktivov\u00e1n enzymem DPP-4, kter\u00fd \u0161t\u011bp\u00ed N-termin\u00e1ln\u00ed dipeptid za pozic\u00ed 2 (His-Ala). T\u00edmto enzymatick\u00fdm zkr\u00e1cen\u00edm vznik\u00e1 GLP-1 (9\u201336), kter\u00fd m\u00e1 v\u00fdrazn\u011b sn\u00ed\u017eenou inzulinotropn\u00ed aktivitu (Mentlein et al., 1993; Holst, 2007).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V\u00fdsledkem je:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Polo\u010das rozpadu nativn\u00edho GLP-1 \u2248 1\u20132 minuty<\/li>\n\n\n\n<li>Rychl\u00e1 ren\u00e1ln\u00ed clearance n\u00e1sleduje po degradaci<\/li>\n\n\n\n<li>Nep\u0159etr\u017eit\u00e1 infuze by byla nutn\u00e1 pro trvalou signalizaci<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tato vnit\u0159n\u00ed nestabilita omezuje pou\u017eit\u00ed nativn\u00edho GLP-1 v modelech s prodlou\u017een\u00fdm metabolick\u00fdm \u00fa\u010dinkem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>2. Mechanizmus enzymatick\u00e9 aktivity DPP-4<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">DPP-4 je serinov\u00e1 prote\u00e1za \u0161iroce exprimovan\u00e1 na endoteli\u00e1ln\u00edch a epiteli\u00e1ln\u00edch povrchech a v rozpustn\u00e9 plazmatick\u00e9 form\u011b. Preferen\u010dn\u011b \u0161t\u011bp\u00ed peptidy obsahuj\u00edc\u00ed prolin nebo alanin na druh\u00e9 pozici N-konce (Deacon, 2019).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V inkretinov\u00e9 biologii:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">GLP-1: His-Ala \u2193<br>GIP: Tyr-Ala \u2193<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160t\u011bpen\u00ed v tomto m\u00edst\u011b naru\u0161uje schopnost aktivace receptoru, co\u017e dramaticky sni\u017euje signaliza\u010dn\u00ed \u00fa\u010dinnost.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Zabr\u00e1n\u011bn\u00ed rozpozn\u00e1n\u00ed DPP-4 je proto prim\u00e1rn\u00edm in\u017een\u00fdrsk\u00fdm c\u00edlem u analog\u016f s prodlou\u017een\u00fdm \u00fa\u010dinkem.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>3. Strukturn\u00ed strategie pro odolnost v\u016f\u010di degradaci DPP-4<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Modern\u00ed analoga inkretin\u016f vyu\u017e\u00edvaj\u00ed n\u011bkolik struktur\u00e1ln\u00edch modifikac\u00ed:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>A. Substituce aminokyselin<\/strong><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">N\u00e1hrada alaninu na pozici 2 nerozpoznateln\u00fdm zbytkem sni\u017euje citlivost v\u016f\u010di \u0161t\u011bpen\u00ed DPP-4.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">P\u0159\u00edklad<br>Semaglutid obsahuje modifikovanou aminokyselinu na pozici 8, co\u017e zvy\u0161uje enzymatickou stabilitu (Lau et al., 2015).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>B. Konjugace mastn\u00fdch kyselin (vazba na albumin)<\/strong><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Nav\u00e1z\u00e1n\u00ed postrann\u00edho \u0159et\u011bzce C18 mastn\u00e9 dikarboxylov\u00e9 kyseliny prost\u0159ednictv\u00edm spaceru umo\u017e\u0148uje reverzibiln\u00ed vazbu na albumin.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vazba na albumin<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sni\u017euje ledvinovou filtraci<\/li>\n\n\n\n<li>Ochrana p\u0159ed enzymatick\u00fdm p\u016fsoben\u00edm<\/li>\n\n\n\n<li>Prodlu\u017euje polo\u010das cirkulace<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Semaglutid vyu\u017e\u00edv\u00e1 acylaci mastnou kyselinou k dosa\u017een\u00ed polo\u010dasu rozpadu p\u0159ibli\u017en\u011b jeden t\u00fdden (Lau et al., 2015; Knudsen &amp; Lau, 2019).<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>C. Sterick\u00e9 br\u00e1n\u011bn\u00ed a molekul\u00e1rn\u00ed st\u00edn\u011bn\u00ed<\/strong><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Objemn\u00e9 p\u0159\u00eddavky postrann\u00edch \u0159et\u011bzc\u016f a molekul\u00e1rn\u00ed p\u0159eskupen\u00ed mohou:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sn\u00ed\u017eit p\u0159\u00edstupnost enzymu<\/li>\n\n\n\n<li>Zlep\u0161it selektivitu receptor\u016f<\/li>\n\n\n\n<li>Zm\u011bnit kinetiku vazby na receptor<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Du\u00e1ln\u00ed a triagonisty vyu\u017e\u00edvaj\u00ed podobn\u00e9 konstruk\u010dn\u00ed principy zvy\u0161uj\u00edc\u00ed stabilitu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>4. Stabilita u du\u00e1ln\u00edch a tripln\u00edch agonist\u016f<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Tirzepatid a retatrutid obsahuj\u00ed struktur\u00e1ln\u00ed modifikace odol\u00e1vaj\u00edc\u00ed degradaci DPP-4 p\u0159i zachov\u00e1n\u00ed afinity k v\u00edce receptor\u016fm.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tirzepatid zahrnuje:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Substituce aminokyselin<\/li>\n\n\n\n<li>Konjugace mastn\u00fdch kyselin pro vazbu na albumin<\/li>\n\n\n\n<li>Modifikace stabilizuj\u00edc\u00ed p\u00e1te\u0159n\u00ed \u0159et\u011bzec<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Tyto in\u017een\u00fdrsk\u00e9 vlastnosti podporuj\u00ed farmakokinetiku s pod\u00e1v\u00e1n\u00edm jednou t\u00fddn\u011b v\u00a0v\u00fdzkumn\u00fdch modelech (Frias et al., 2021).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Trojit\u00e1 agonistick\u00e1 slou\u010denina tuto strategii roz\u0161i\u0159uje o za\u010dlen\u011bn\u00ed afinity k receptoru pro glukagon p\u0159i zachov\u00e1n\u00ed enzymatick\u00e9 stability (Jastreboff et al., 2023).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>5. Farmakokinetick\u00e9 d\u016fsledky<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Strategie pro prodlou\u017een\u00ed polo\u010dasu rozpadu vedou k:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sn\u00ed\u017een\u00e1 frekvence d\u00e1vkov\u00e1n\u00ed<\/li>\n\n\n\n<li>Trval\u00e1 aktivace receptoru<\/li>\n\n\n\n<li>Stabiln\u011bj\u0161\u00ed expozice plazm\u011b<\/li>\n\n\n\n<li>Vylep\u0161en\u00e9 modelov\u00e1n\u00ed chronick\u00fdch sign\u00e1ln\u00edch drah<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">To odli\u0161uje modern\u00ed analogony inkretin\u016f od model\u016f s infuz\u00ed nativn\u00edho hormonu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Z hlediska n\u00e1vrhu v\u00fdzkumu:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nativn\u00ed GLP-1 = model akutn\u00ed signalizace<\/li>\n\n\n\n<li>In\u017een\u00fdrsk\u00e9 analogony = model trval\u00e9 aktivace receptoru<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>6. Vazba na albumin a distribuce<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Vazba na albumin prodlu\u017euje syst\u00e9movou expozici prost\u0159ednictv\u00edm reverzibiln\u00ed vazebn\u00e9 rovnov\u00e1hy. Proto\u017ee je albumin v plazm\u011b hojn\u011b zastoupen, peptidy acylovan\u00e9 mastn\u00fdmi kyselinami udr\u017euj\u00ed cirkuluj\u00edc\u00ed z\u00e1soby, kter\u00e9 se \u010dasem pomalu disociuj\u00ed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tato strategie je nyn\u00ed \u0161iroce pou\u017e\u00edv\u00e1na v peptidov\u00e9 terapii nad r\u00e1mec inkretinov\u00e9 biologie (Knudsen &amp; Lau, 2019).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"\/cs\/product\/semaglutide-10-mg\/\" data-type=\"product\" data-id=\"303\">Semaglutid <\/a>p\u0159edstavuje sofistikovanou aplikaci tohoto in\u017een\u00fdrsk\u00e9ho p\u0159\u00edstupu v r\u00e1mci v\u00fdzkumu agonist\u016f GLP-1 receptor\u016f.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>7. Porovn\u00e1n\u00ed strategi\u00ed stability<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Strategie<\/strong><\/td><td><strong>\u00da\u010del<\/strong><\/td><td><strong>Uk\u00e1zkov\u00e1 aplikace<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Substituce aminokyselin<\/td><td>Zabr\u00e1nit \u0161t\u011bpen\u00ed DPP-4<\/td><td>Analoga GLP-1<\/td><\/tr><tr><td>Konjugace mastn\u00fdch kyselin<\/td><td>Vazba na albumin a prodlou\u017een\u00ed polo\u010dasu<\/td><td><a href=\"\/cs\/product\/semaglutide-10-mg\/\" data-type=\"product\" data-id=\"303\">Semaglutid<\/a><\/td><\/tr><tr><td>\u00daprava p\u00e1te\u0159e<\/td><td>Stabilita a receptorov\u00e1 selektivita<\/td><td>Du\u00e1ln\u00ed\/trojn\u00e1sobn\u00ed agonists<\/td><\/tr><tr><td>N\u00e1vrh s v\u00edcero receptory<\/td><td>Roz\u0161\u00ed\u0159en\u00e1 signalizace<\/td><td><a href=\"\/cs\/product\/tirzepatide-10-mg\/\" data-type=\"product\" data-id=\"309\">Tirzepatid<\/a>, <a href=\"\/cs\/product\/retatrutide-10-mg\/\" data-type=\"product\" data-id=\"331\">Retatrutid<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>8. \u00davahy o experiment\u00e1ln\u00edm designu<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">P\u0159i pr\u00e1ci s upraven\u00fdmi analogy inkretinu:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Doporu\u010duje se skladov\u00e1n\u00ed v chladic\u00edm \u0159et\u011bzci (2\u20138 \u00b0C)<\/li>\n\n\n\n<li>Zabra\u0148te opakovan\u00fdm cykl\u016fm zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed<\/li>\n\n\n\n<li>Rekonstituujte za sterili\u010dn\u00edch podm\u00ednek<\/li>\n\n\n\n<li>Zva\u017ete farmakokinetickou dobu trv\u00e1n\u00ed v n\u00e1vrhu modelu<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Trval\u00e1 aktivace receptor\u016f m\u016f\u017ee ve srovn\u00e1n\u00ed s modely akutn\u00ed expozice pozm\u011bnit n\u00e1slednou adaptivn\u00ed sign\u00e1ln\u00ed dr\u00e1hu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>9. \u010casto kladen\u00e9 ot\u00e1zky<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pro\u010d se nativn\u00ed GLP-1 tak rychle rozkl\u00e1d\u00e1?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Proto\u017ee DPP-4 rychle \u0161t\u011bp\u00ed N-termin\u00e1ln\u00ed dipeptid, \u010d\u00edm\u017e ho \u010din\u00ed p\u0159ev\u00e1\u017en\u011b neaktivn\u00edm.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Jak semaglutid odol\u00e1v\u00e1 degradaci?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pomoc\u00ed substituce aminokyselin a konjugace mastn\u00fdch kyselin, kter\u00e1 umo\u017e\u0148uje vazbu na albumin a sterickou ochranu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vyu\u017e\u00edvaj\u00ed du\u00e1ln\u00ed a triagonisty podobn\u00e9 strategie?<\/strong> Ano. Obsahuj\u00ed struktur\u00e1ln\u00ed modifikace, kter\u00e9 zabra\u0148uj\u00ed enzymatick\u00e9mu \u0161t\u011bpen\u00ed p\u0159i zachov\u00e1n\u00ed receptorov\u00e9 afinity<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>10. Souvisej\u00edc\u00ed metabolick\u00e9 v\u00fdzkumn\u00e9 slou\u010deniny<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"\/cs\/product\/semaglutide-10-mg\/\" data-type=\"product\" data-id=\"303\">Semaglutid <\/a>(agonista GLP-1 receptor\u016f)<\/li>\n\n\n\n<li><a href=\"\/cs\/product\/tirzepatide-10-mg\/\" data-type=\"product\" data-id=\"309\">Tirzepatid <\/a>(du\u00e1ln\u00ed agonista GLP-1\/GIP)<\/li>\n\n\n\n<li><a href=\"\/cs\/product\/retatrutide-10-mg\/\" data-type=\"product\" data-id=\"331\">Retatrutid <\/a>(trojn\u00e1sobn\u00fd agonista GLP-1\/GIP\/glukagonu)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Proch\u00e1zet v\u0161echny slou\u010deniny na b\u00e1zi inkretinu v <strong><a href=\"https:\/\/life-peptide.com\/cs\/glp-1-metabolic-research-guide\/\" data-type=\"page\" data-id=\"529\">Metabolick\u00fd v\u00fdzkum<\/a>.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>V\u011bdeck\u00e9 odkazy<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Mentlein R a kol. Dipeptidyl-peptid\u00e1za IV hydrolyzuje gastrick\u00fd inhibitory peptid a glukagonu podobn\u00fd peptid-1. <em>European Journal of Biochemistry<\/em>. 1993.<br>Holst JJ. Fyziologie glukagonu podobn\u00e9ho peptidu 1. <em>Physiological Reviews<\/em>. 2007.<br>Deacon CF. Fyziologie a farmakologie DPP-4. <em>Frontiers in Endocrinology<\/em>. 2019.<br>Lau J et al. Objev jedenkr\u00e1t t\u00fddn\u011b pod\u00e1van\u00e9ho analogu GLP-1 semaglutidu. <em>Journal of Medicinal Chemistry<\/em>. 2015.<br>Knudsen LB, Lau J. Objev a v\u00fdvoj liraglutidu a semaglutidu. <em>Frontiers in Endocrinology<\/em>. 2019.<br>Frias JP a kol. Tirzepatid versus semaglutid jednou t\u00fddn\u011b u diabetu 2. typu. <em>NEJM<\/em>. 2021.<br>Jastreboff AM et al. Trojn\u00e1sobn\u00fd hormon\u00e1ln\u00ed receptorov\u00fd agonista retatrutid. <em>NEJM<\/em>. 2023.<\/p>","protected":false},"excerpt":{"rendered":"<p>DPP-4 degradation and structural engineering in incretin analogues Enzymatic instability and half-life extension strategies in GLP-1 research Native incretin hormones such as GLP-1 and GIP are rapidly degraded in circulation by the enzyme dipeptidyl peptidase-4 (DPP-4), resulting in extremely short biological half-lives. In metabolic research, structural peptide engineering is used to overcome this rapid enzymatic [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-568","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/pages\/568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/comments?post=568"}],"version-history":[{"count":4,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/pages\/568\/revisions"}],"predecessor-version":[{"id":611,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/pages\/568\/revisions\/611"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media?parent=568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}